Definitions in Hemophilia: Resolved and Unresolved Issues
暂无分享,去创建一个
[1] R. Ljung,et al. Definitions in hemophilia: communication from the SSC of the ISTH , 2014, Journal of thrombosis and haemostasis : JTH.
[2] V. Blanchette,et al. Assessment of outcomes , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.
[3] J. Mahlangu,et al. Guidelines for the management of hemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[4] R. Liesner,et al. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition) , 2013, British journal of haematology.
[5] P. Babyn,et al. Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada , 2012, Journal of Thrombosis and Haemostasis.
[6] T. Lambert,et al. Tertiary prophylaxis in adults: is there a rationale? , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.
[7] C. Miller,et al. Validation of Nijmegen–Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance , 2012, Journal of thrombosis and haemostasis : JTH.
[8] J. Oldenburg,et al. Low‐titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half‐life after immune tolerance induction , 2012, Journal of thrombosis and haemostasis : JTH.
[9] D. Grobbee,et al. Clinical severity of haemophilia A: does the classification of the 1950s still stand? , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.
[10] B. Verbruggen,et al. The between-Laboratory Variation of Factor VIII Inhibitor Testing: The Experience of the External Quality Assessment Program of the ECAT Foundation , 2009, Seminars in thrombosis and hemostasis.
[11] A. Iorio,et al. Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. , 2009, Blood.
[12] V. Blanchette,et al. Definitions for haemophilia prophylaxis and its outcomes: The Canadian Consensus Study , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.
[13] M. Makris,et al. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors , 2006, Thrombosis and Haemostasis.
[14] S. Donadel-Claeyssens. Current co‐ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management) , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[15] V. Blanchette,et al. A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.
[16] J. Astermark,et al. Consensus perspectives on prophylactic therapy for haemophilia: summary statement , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.
[17] D. Grobbee,et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. , 2002, Blood.
[18] F. Rosendaal,et al. Definitions in Hemophilia , 2001, Thrombosis and Haemostasis.
[19] J. Astermark,et al. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized , 1999, British journal of haematology.
[20] M. Power,et al. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment , 1998, Psychological Medicine.
[21] M. van den Berg,et al. The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability , 1995, Thrombosis and Haemostasis.
[22] H. Pettersson,et al. A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs , 1994, Journal of internal medicine.
[23] E. Berntorp,et al. Pharmacokinetics of Factor VIII in Humans , 1992, Clinical pharmacokinetics.
[24] R. G. Macfarlane,et al. Haemophilia and Related Conditions: A Survey of 187 Cases , 1958, British journal of haematology.
[25] B. O’Mahony. An introduction to key concepts in health economics for haemophilia organisations , 2011 .
[26] J. Stockman. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia , 2009 .
[27] Eric F. Gardner,et al. Summary Statement , 1946 .